Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease. (Q41276257)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 October 2015

Language	Label	Description	Also known as
English	Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.	scientific article published on 2 October 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Vendula Sepsova

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Martina Hrabinová

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Ondrej Soukup

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Marketa Pasdiorova

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Lukas Hroch

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Petr Jost

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kamil Kuca

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Dominykas Zala

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Rona R Ramsay

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

José Marco-Contelles

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

2 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1264-1269

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427608%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A century of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The amyloid hypothesis for Alzheimer's disease: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Development of tau aggregation inhibitors for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Oxidative stress in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Acetylcholinesterase in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Multi-target-directed ligands to combat neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Monoamine oxidase-B inhibition in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The therapeutic potential of monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Reactive oxygen species production by monoamine oxidases in intact cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of [...]

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Multipotent, permeable drug ASS234 inhibits Aβ aggregation, possesses antioxidant properties and protects from Aβ-induced apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

An update on amine oxidase inhibitors: multifaceted drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Inhibition of monoamine oxidase A by beta-carboline derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

beta-Carboline alkaloids: biochemical and pharmacological functions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Recent advances in the Friedländer reaction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

The role of antioxidants in the chemistry of oxidative stress: A review

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

A resurrection of 7-MEOTA: a comparison with tacrine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

High throughput artificial membrane permeability assay for blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

21 January 2018

A Facile Copper-Catalyzed One-Pot Domino Synthesis of 5,12-Dihydroindolo[2,1-b]quinazolines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500383

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41276257&oldid=2095789495"